Industry seeks trust and louder voice in HTA evolution, says Efpia
This article was originally published in SRA
Executive Summary
The pharmaceutical industry has, so far, had only narrow input into a pilot project that was launched by the European Network for Health Technology Assessment (EUnetHTA) to evaluate how to improve and accelerate relative effectiveness assessments for drugs1.